The Molecular Pathology of Autoimmune Diseases : A Complete Study Guide by Argyrios N Theofilopoulos (Editor), Constantin A. Bona (Editor)
The Molecular Pathology of Autoimmune Diseases is a comprehensive and authoritative reference that explores the molecular and genetic basis of autoimmune disorders, bringing together contributions from leading experts in immunology and molecular medicine.
This volume provides an integrated understanding of how loss of immune tolerance leads to the development of diverse autoimmune diseases, linking fundamental immunological mechanisms with real clinical manifestations.
It offers a deep exploration of key drivers of disease, including immune signaling pathways, genetic susceptibility, and environmental triggers, making it a highly structured resource for understanding disease progression from mechanism to pathology.
The book also highlights cutting-edge therapeutic directions such as bone marrow transplantation and targeted immunotherapy, reflecting the most advanced strategies in modern autoimmune disease management.
Overall, this work stands as an essential and highly specialized reference for students, researchers, and clinicians seeking a rigorous and up-to-date understanding of autoimmunity, combining scientific depth with clinical relevance in a way that makes it a valuable addition to any biomedical library. GET IT
The book The Molecular Pathology of Autoimmune Diseases is organized into five major sections that progressively move from fundamental immunological mechanisms to disease-specific pathology and finally to therapeutic strategies.
SECTION I: BASIC ASPECTS OF AUTOIMMUNE PROCESSES (Chapters 1–17)
This section establishes the fundamental immunological and molecular framework required to understand autoimmune diseases. It focuses on how immune tolerance is normally maintained and how its failure leads to autoimmunity.
The chapters collectively explain the mechanisms of B cell tolerance and how its breakdown leads to the production of autoantibodies, which are central drivers of autoimmune pathology. It also explores the genetic origin of human and murine autoantibodies, highlighting the role of inherited susceptibility in shaping immune responses.
A major focus is placed on T cell development and tolerance, particularly the processes that eliminate or regulate autoreactive T cells during immune system maturation. In addition, the section examines T cell receptor (TCR) signaling pathways, structural recognition of antigens, and how these molecular interactions contribute to autoimmune activation.
The role of cytokine balance (Th1/Th2 paradigm) is discussed in detail, emphasizing how immune polarization influences disease outcomes. Other key mechanisms include apoptosis defects, antigen processing and presentation, and molecular mimicry, all of which contribute to immune system failure in distinguishing self from non-self.
This section also introduces regulatory systems such as the complement system, chemokine-mediated leukocyte trafficking, and adhesion molecules, which collectively regulate immune cell movement and activation during autoimmune responses.
Overall, this section provides the essential molecular basis of immune tolerance breakdown, which is the initiating event in all autoimmune diseases.
SECTION II: SYSTEMIC AUTOIMMUNE DISEASES (Chapters 18–28)
This section focuses on systemic autoimmune diseases characterized by widespread immune dysregulation affecting multiple organs simultaneously.
It begins with detailed molecular and clinical insights into Systemic Lupus Erythematosus (SLE), a prototypical systemic autoimmune disease driven by autoantibody formation, immune complex deposition, and chronic inflammation.
The section also explores Rheumatoid Arthritis, emphasizing the genetic and immunological mechanisms responsible for persistent synovial inflammation and joint destruction. Special attention is given to the role of T cell–B cell interactions and cytokine-driven tissue damage.
Additional chapters analyze Sjögren’s Syndrome, focusing on autoimmune destruction of exocrine glands, and Systemic Sclerosis (Scleroderma), which is characterized by fibrosis and vascular dysfunction mediated by immune dysregulation.
The pathogenesis of systemic vasculitis is also examined, highlighting immune-mediated damage to blood vessels and the role of circulating immune complexes.
A significant component of this section is the use of experimental animal models, which provide mechanistic insights into disease progression and allow the study of genetic and environmental interactions in systemic autoimmunity.
Overall, this section explains how systemic immune dysregulation leads to multi-organ pathology through persistent chronic inflammation, autoantibody activity, and immune complex-mediated tissue injury.
SECTION III: ORGAN-SPECIFIC AUTOIMMUNE DISEASES (Chapters 29–60)
This is the largest section of the book and focuses on autoimmune diseases that selectively target specific organs or tissues.
The hematologic subsection describes diseases such as autoimmune hemolytic anemia, immune thrombocytopenic purpura, and autoimmune neutropenia, all of which involve immune-mediated destruction of blood cells through autoantibodies and complement activation.
The endocrine subsection examines diseases such as Type 1 diabetes mellitus, Hashimoto’s thyroiditis, Graves’ disease, and autoimmune polyglandular syndromes. These conditions result from immune-mediated destruction or stimulation of hormone-producing glands, leading to severe metabolic and hormonal imbalance.
Neurological autoimmune diseases are represented by Multiple Sclerosis, where immune responses target myelin sheaths, leading to neurodegeneration and impaired neural signaling. Experimental models such as experimental autoimmune encephalomyelitis (EAE) are used to study disease mechanisms.
Muscle-related autoimmune diseases such as Myasthenia Gravis are also discussed, focusing on autoantibody-mediated disruption of neuromuscular junction signaling.
Skin diseases such as vitiligo and pemphigus illustrate immune-mediated destruction of melanocytes and epidermal adhesion molecules, respectively.
The gastrointestinal section covers diseases such as inflammatory bowel disease, autoimmune gastritis, and Behçet’s disease, emphasizing dysregulation of mucosal immunity and chronic intestinal inflammation.
Hepatic autoimmune diseases, including autoimmune hepatitis and primary biliary cirrhosis, are characterized by immune-mediated destruction of liver tissue and bile ducts.
Cardiovascular autoimmune disorders include autoimmune myocarditis and immune involvement in atherosclerosis, highlighting the role of inflammation in cardiovascular pathology.
Finally, renal, ocular, and reproductive autoimmune diseases demonstrate how immune responses can target highly specialized tissues, leading to organ-specific dysfunction and chronic inflammatory damage.
Overall, this section demonstrates that organ-specific autoimmunity arises from targeted immune attacks against tissue-specific antigens, leading to localized but often severe pathological outcomes.
SECTION IV: ASSOCIATED AUTOIMMUNITY (Chapters 61–63)
This section examines conditions in which autoimmunity is associated with external or systemic biological factors rather than being purely primary autoimmune disorders.
It explores the relationship between HIV infection and immune dysregulation, showing how viral infection can trigger or exacerbate autoimmune responses through chronic immune activation and loss of immune regulation.
The section also discusses transplantation and autoimmunity, focusing on how immune tolerance is disrupted following transplantation procedures and how residual immune responses can persist even after tolerance induction.
Another key topic is age-associated autoimmunity, which describes how aging alters immune regulation, leading to increased susceptibility to autoreactive immune responses and reduced tolerance mechanisms.
This section highlights that autoimmunity is not always a primary disease but can be influenced by infection, immune manipulation, and aging processes, which modify immune homeostasis.
SECTION V: IMMUNOTHERAPEUTIC APPROACHES (Chapters 64–65)
The final section addresses modern therapeutic strategies for autoimmune diseases, emphasizing the transition from understanding pathology to clinical intervention.
It presents the concept of autoimmune diseases as potential stem cell disorders, where defects in hematopoietic or immune stem cell populations contribute to disease development.
A major focus is placed on allogeneic bone marrow transplantation, which can effectively reset the immune system and restore immune tolerance in severe autoimmune conditions.
The section also discusses broader strategies of immunointervention, including immune suppression, immune modulation, and targeted therapies designed to selectively regulate pathogenic immune responses without compromising overall immune function.
Overall, this section highlights the evolution of autoimmune disease treatment from generalized immunosuppression to advanced immune system reprogramming and targeted immunotherapy.